Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at US$ 929 million in 2024 and is forecast to a readjusted size of USD 1686 million by 2031 with a CAGR of 9.0% during review period.

Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and tries to limit damage to healthy cells.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Bladder Cancer Targeted Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Bladder Cancer Targeted Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Bladder Cancer Targeted Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Bladder Cancer Targeted Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Bladder Cancer Targeted Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bladder Cancer Targeted Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bladder Cancer Targeted Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck KGaA, Roche, Astellas, Janssen Biotech, Bristol-Myers Squibb, Merck & Co., Gilead Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Bladder Cancer Targeted Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Atezolizumab (Tecentriq)
    Avelumab (Bavencio)
    Erdafitinib (Balversa)
    Other

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Pfizer
    Merck KGaA
    Roche
    Astellas
    Janssen Biotech
    Bristol-Myers Squibb
    Merck & Co.
    Gilead Sciences

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bladder Cancer Targeted Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bladder Cancer Targeted Drug, with revenue, gross margin, and global market share of Bladder Cancer Targeted Drug from 2020 to 2025.
Chapter 3, the Bladder Cancer Targeted Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Bladder Cancer Targeted Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bladder Cancer Targeted Drug.
Chapter 13, to describe Bladder Cancer Targeted Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Bladder Cancer Targeted Drug by Type
        1.3.1 Overview: Global Bladder Cancer Targeted Drug Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Bladder Cancer Targeted Drug Consumption Value Market Share by Type in 2024
        1.3.3 Atezolizumab (Tecentriq)
        1.3.4 Avelumab (Bavencio)
        1.3.5 Erdafitinib (Balversa)
        1.3.6 Other
    1.4 Global Bladder Cancer Targeted Drug Market by Application
        1.4.1 Overview: Global Bladder Cancer Targeted Drug Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Bladder Cancer Targeted Drug Market Size & Forecast
    1.6 Global Bladder Cancer Targeted Drug Market Size and Forecast by Region
        1.6.1 Global Bladder Cancer Targeted Drug Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Bladder Cancer Targeted Drug Market Size by Region, (2020-2031)
        1.6.3 North America Bladder Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.4 Europe Bladder Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Bladder Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.6 South America Bladder Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Bladder Cancer Targeted Drug Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Bladder Cancer Targeted Drug Product and Solutions
        2.1.4 Pfizer Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Merck KGaA
        2.2.1 Merck KGaA Details
        2.2.2 Merck KGaA Major Business
        2.2.3 Merck KGaA Bladder Cancer Targeted Drug Product and Solutions
        2.2.4 Merck KGaA Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Merck KGaA Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Bladder Cancer Targeted Drug Product and Solutions
        2.3.4 Roche Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 Astellas
        2.4.1 Astellas Details
        2.4.2 Astellas Major Business
        2.4.3 Astellas Bladder Cancer Targeted Drug Product and Solutions
        2.4.4 Astellas Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Astellas Recent Developments and Future Plans
    2.5 Janssen Biotech
        2.5.1 Janssen Biotech Details
        2.5.2 Janssen Biotech Major Business
        2.5.3 Janssen Biotech Bladder Cancer Targeted Drug Product and Solutions
        2.5.4 Janssen Biotech Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Janssen Biotech Recent Developments and Future Plans
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Solutions
        2.6.4 Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.7 Merck & Co.
        2.7.1 Merck & Co. Details
        2.7.2 Merck & Co. Major Business
        2.7.3 Merck & Co. Bladder Cancer Targeted Drug Product and Solutions
        2.7.4 Merck & Co. Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Merck & Co. Recent Developments and Future Plans
    2.8 Gilead Sciences
        2.8.1 Gilead Sciences Details
        2.8.2 Gilead Sciences Major Business
        2.8.3 Gilead Sciences Bladder Cancer Targeted Drug Product and Solutions
        2.8.4 Gilead Sciences Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Gilead Sciences Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Bladder Cancer Targeted Drug Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Bladder Cancer Targeted Drug by Company Revenue
        3.2.2 Top 3 Bladder Cancer Targeted Drug Players Market Share in 2024
        3.2.3 Top 6 Bladder Cancer Targeted Drug Players Market Share in 2024
    3.3 Bladder Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.3.1 Bladder Cancer Targeted Drug Market: Region Footprint
        3.3.2 Bladder Cancer Targeted Drug Market: Company Product Type Footprint
        3.3.3 Bladder Cancer Targeted Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Bladder Cancer Targeted Drug Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Bladder Cancer Targeted Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2025)
    5.2 Global Bladder Cancer Targeted Drug Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Bladder Cancer Targeted Drug Consumption Value by Type (2020-2031)
    6.2 North America Bladder Cancer Targeted Drug Market Size by Application (2020-2031)
    6.3 North America Bladder Cancer Targeted Drug Market Size by Country
        6.3.1 North America Bladder Cancer Targeted Drug Consumption Value by Country (2020-2031)
        6.3.2 United States Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        6.3.3 Canada Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        6.3.4 Mexico Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Bladder Cancer Targeted Drug Consumption Value by Type (2020-2031)
    7.2 Europe Bladder Cancer Targeted Drug Consumption Value by Application (2020-2031)
    7.3 Europe Bladder Cancer Targeted Drug Market Size by Country
        7.3.1 Europe Bladder Cancer Targeted Drug Consumption Value by Country (2020-2031)
        7.3.2 Germany Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.3 France Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.5 Russia Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.6 Italy Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region
        8.3.1 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2020-2031)
        8.3.2 China Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.3 Japan Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.4 South Korea Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.5 India Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.7 Australia Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Bladder Cancer Targeted Drug Consumption Value by Type (2020-2031)
    9.2 South America Bladder Cancer Targeted Drug Consumption Value by Application (2020-2031)
    9.3 South America Bladder Cancer Targeted Drug Market Size by Country
        9.3.1 South America Bladder Cancer Targeted Drug Consumption Value by Country (2020-2031)
        9.3.2 Brazil Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        9.3.3 Argentina Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country
        10.3.1 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2020-2031)
        10.3.2 Turkey Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)
        10.3.4 UAE Bladder Cancer Targeted Drug Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Bladder Cancer Targeted Drug Market Drivers
    11.2 Bladder Cancer Targeted Drug Market Restraints
    11.3 Bladder Cancer Targeted Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Bladder Cancer Targeted Drug Industry Chain
    12.2 Bladder Cancer Targeted Drug Upstream Analysis
    12.3 Bladder Cancer Targeted Drug Midstream Analysis
    12.4 Bladder Cancer Targeted Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Bladder Cancer Targeted Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Bladder Cancer Targeted Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Bladder Cancer Targeted Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Bladder Cancer Targeted Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Pfizer Company Information, Head Office, and Major Competitors
 Table 6. Pfizer Major Business
 Table 7. Pfizer Bladder Cancer Targeted Drug Product and Solutions
 Table 8. Pfizer Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Pfizer Recent Developments and Future Plans
 Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
 Table 11. Merck KGaA Major Business
 Table 12. Merck KGaA Bladder Cancer Targeted Drug Product and Solutions
 Table 13. Merck KGaA Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Merck KGaA Recent Developments and Future Plans
 Table 15. Roche Company Information, Head Office, and Major Competitors
 Table 16. Roche Major Business
 Table 17. Roche Bladder Cancer Targeted Drug Product and Solutions
 Table 18. Roche Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Astellas Company Information, Head Office, and Major Competitors
 Table 20. Astellas Major Business
 Table 21. Astellas Bladder Cancer Targeted Drug Product and Solutions
 Table 22. Astellas Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Astellas Recent Developments and Future Plans
 Table 24. Janssen Biotech Company Information, Head Office, and Major Competitors
 Table 25. Janssen Biotech Major Business
 Table 26. Janssen Biotech Bladder Cancer Targeted Drug Product and Solutions
 Table 27. Janssen Biotech Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Janssen Biotech Recent Developments and Future Plans
 Table 29. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 30. Bristol-Myers Squibb Major Business
 Table 31. Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Solutions
 Table 32. Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Bristol-Myers Squibb Recent Developments and Future Plans
 Table 34. Merck & Co. Company Information, Head Office, and Major Competitors
 Table 35. Merck & Co. Major Business
 Table 36. Merck & Co. Bladder Cancer Targeted Drug Product and Solutions
 Table 37. Merck & Co. Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Merck & Co. Recent Developments and Future Plans
 Table 39. Gilead Sciences Company Information, Head Office, and Major Competitors
 Table 40. Gilead Sciences Major Business
 Table 41. Gilead Sciences Bladder Cancer Targeted Drug Product and Solutions
 Table 42. Gilead Sciences Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Gilead Sciences Recent Developments and Future Plans
 Table 44. Global Bladder Cancer Targeted Drug Revenue (USD Million) by Players (2020-2025)
 Table 45. Global Bladder Cancer Targeted Drug Revenue Share by Players (2020-2025)
 Table 46. Breakdown of Bladder Cancer Targeted Drug by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 47. Market Position of Players in Bladder Cancer Targeted Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 48. Head Office of Key Bladder Cancer Targeted Drug Players
 Table 49. Bladder Cancer Targeted Drug Market: Company Product Type Footprint
 Table 50. Bladder Cancer Targeted Drug Market: Company Product Application Footprint
 Table 51. Bladder Cancer Targeted Drug New Market Entrants and Barriers to Market Entry
 Table 52. Bladder Cancer Targeted Drug Mergers, Acquisition, Agreements, and Collaborations
 Table 53. Global Bladder Cancer Targeted Drug Consumption Value (USD Million) by Type (2020-2025)
 Table 54. Global Bladder Cancer Targeted Drug Consumption Value Share by Type (2020-2025)
 Table 55. Global Bladder Cancer Targeted Drug Consumption Value Forecast by Type (2026-2031)
 Table 56. Global Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025)
 Table 57. Global Bladder Cancer Targeted Drug Consumption Value Forecast by Application (2026-2031)
 Table 58. North America Bladder Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 59. North America Bladder Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 60. North America Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 61. North America Bladder Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 62. North America Bladder Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 63. North America Bladder Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 64. Europe Bladder Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 65. Europe Bladder Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 66. Europe Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 67. Europe Bladder Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 68. Europe Bladder Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 69. Europe Bladder Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 70. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 71. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 72. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 73. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 74. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 75. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 76. South America Bladder Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 77. South America Bladder Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 78. South America Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 79. South America Bladder Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 80. South America Bladder Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 81. South America Bladder Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 82. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 83. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 84. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 85. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 86. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 87. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 88. Global Key Players of Bladder Cancer Targeted Drug Upstream (Raw Materials)
 Table 89. Global Bladder Cancer Targeted Drug Typical Customers


List of Figures
 Figure 1. Bladder Cancer Targeted Drug Picture
 Figure 2. Global Bladder Cancer Targeted Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Type in 2024
 Figure 4. Atezolizumab (Tecentriq)
 Figure 5. Avelumab (Bavencio)
 Figure 6. Erdafitinib (Balversa)
 Figure 7. Other
 Figure 8. Global Bladder Cancer Targeted Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 9. Bladder Cancer Targeted Drug Consumption Value Market Share by Application in 2024
 Figure 10. Hospital Picture
 Figure 11. Retail Pharmacy Picture
 Figure 12. Other Picture
 Figure 13. Global Bladder Cancer Targeted Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 14. Global Bladder Cancer Targeted Drug Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 15. Global Market Bladder Cancer Targeted Drug Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 16. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Region (2020-2031)
 Figure 17. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Region in 2024
 Figure 18. North America Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 19. Europe Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 20. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 21. South America Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 22. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 23. Company Three Recent Developments and Future Plans
 Figure 24. Global Bladder Cancer Targeted Drug Revenue Share by Players in 2024
 Figure 25. Bladder Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 26. Market Share of Bladder Cancer Targeted Drug by Player Revenue in 2024
 Figure 27. Top 3 Bladder Cancer Targeted Drug Players Market Share in 2024
 Figure 28. Top 6 Bladder Cancer Targeted Drug Players Market Share in 2024
 Figure 29. Global Bladder Cancer Targeted Drug Consumption Value Share by Type (2020-2025)
 Figure 30. Global Bladder Cancer Targeted Drug Market Share Forecast by Type (2026-2031)
 Figure 31. Global Bladder Cancer Targeted Drug Consumption Value Share by Application (2020-2025)
 Figure 32. Global Bladder Cancer Targeted Drug Market Share Forecast by Application (2026-2031)
 Figure 33. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 34. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 35. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 36. United States Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 37. Canada Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 38. Mexico Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 39. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 40. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 41. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 42. Germany Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 43. France Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 44. United Kingdom Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 45. Russia Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 46. Italy Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 47. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 48. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 49. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Region (2020-2031)
 Figure 50. China Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 51. Japan Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 52. South Korea Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 53. India Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 54. Southeast Asia Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 55. Australia Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 56. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 57. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 58. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 59. Brazil Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 60. Argentina Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 61. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 62. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 63. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 64. Turkey Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 65. Saudi Arabia Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 66. UAE Bladder Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 67. Bladder Cancer Targeted Drug Market Drivers
 Figure 68. Bladder Cancer Targeted Drug Market Restraints
 Figure 69. Bladder Cancer Targeted Drug Market Trends
 Figure 70. Porters Five Forces Analysis
 Figure 71. Bladder Cancer Targeted Drug Industrial Chain
 Figure 72. Methodology
 Figure 73. Research Process and Data Source

Companies Mentioned

Pfizer
Merck KGaA
Roche
Astellas
Janssen Biotech
Bristol-Myers Squibb
Merck & Co.
Gilead Sciences